| 2025-12-09 |
详情>>
内部人交易：
PRYOR DANIEL A股份减少666.00股
|
| 2025-11-06 |
详情>>
股本变动：
变动后总股本5718.94万股
|
| 2025-11-06 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-11.64美元,归母净利润-6.64亿美元,同比去年增长-443.44%
|
| 2025-11-06 |
财报披露：
美东时间 2025-11-06 盘前发布财报
|
| 2025-08-07 |
详情>>
业绩披露：
2025年中报每股收益-1.62美元,归母净利润-9270.5万美元,同比去年增长-2.28%
|
| 2025-05-08 |
详情>>
业绩披露：
2025年一季报每股收益-0.98美元,归母净利润-5596.6万美元,同比去年增长22.27%
|
| 2025-04-11 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the nine members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
3.To approve the compensation of our named executive officers on an advisory basis (“say-on-pay”);
4.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2025-02-26 |
详情>>
业绩披露：
2022年年报每股收益-0.25美元,归母净利润-1329.2万美元,同比去年增长-118.55%
|
| 2025-02-26 |
详情>>
业绩披露：
2024年年报每股收益-14.93美元,归母净利润-8.25亿美元,同比去年增长-2381.87%
|
| 2024-11-06 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-2.23美元,归母净利润-1.22亿美元,同比去年增长-237.22%
|
| 2024-08-07 |
详情>>
业绩披露：
2023年中报每股收益-0.61美元,归母净利润-3334.5万美元,同比去年增长-136.27%
|
| 2024-08-07 |
详情>>
业绩披露：
2024年中报每股收益-1.65美元,归母净利润-9063.6万美元,同比去年增长-171.81%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益-1.32美元,归母净利润-7199.8万美元,同比去年增长-208.34%
|
| 2024-04-05 |
股东大会：
将于2024-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the ten members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2024;
3.To approve the compensation of our named executive officers on an advisory basis (“say-on-pay”);
4.To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan;
5.To amend the Company’s Amended and Restated Certificate of Incorporation to reflect new Delaware law provisions regarding officer exculpation;
6.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2024-02-22 |
详情>>
业绩披露：
2023年年报每股收益-0.61美元,归母净利润-3326.1万美元,同比去年增长-150.23%
|
| 2023-11-07 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-0.67美元,归母净利润-3622.5万美元,同比去年增长-243.12%
|
| 2023-03-31 |
股东大会：
将于2023-05-16召开股东大会
会议内容 ▼▲
- 1.To elect the ten members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2023;
3.To approve the compensation of our named executive officers on an advisory basis (“say-on-pay”);
4.To hold an advisory vote on the frequency of future advisory votes to approve the compensation of our named executive officers (“say-on-frequency”);
5.To approve the Enovis Corporation 2023 Non-Qualified Stock Purchase Plan;
6.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-04-28 |
股东大会：
将于2022-06-07召开股东大会
会议内容 ▼▲
- 1.To elect the eleven members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
3.To approve the compensation of our named executive officers on an advisory basis (“say-on-pay”);
4.To approve an amendment to the Enovis Corporation 2020 Omnibus Incentive Plan;
5.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2022-03-14 |
详情>>
拆分方案：
每3.0000合并分成1.0000股
|
| 2022-01-18 |
股东大会：
将于2022-02-28召开股东大会
会议内容 ▼▲
- 1.To approve and adopt an amendment to our Amended and Restated Certificate of Incorporation to effect (a) a reverse stock split of our common stock, at one of three reverse stock split ratios, one-for-two, one-for-three or one-for-four, with the exact ratio to be determined by our Board of Directors (the “Board”) at a later date, and (b) if and when the reverse stock split is effected, a corresponding reduction in the number of authorized shares of our common stock by the selected reverse stock split ratio (the “Reverse Stock Split Proposal”);
2.To approve one or more adjournments of the Special Meeting, if necessary, to solicit additional proxies if there are not sufficient votes to approve the Reverse Stock Split Proposal at the Special Meeting or any adjournment(s) thereof (the “Adjournment Proposal”).
|
| 2021-04-01 |
股东大会：
将于2021-05-12召开股东大会
会议内容 ▼▲
- 1.To elect the eleven members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2021;
3.To approve the compensation of our named executive officers on an advisory basis (“say-on-pay”);
4.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2021-03-15 |
热点提醒：
美股今天进入夏令时交易，盘前交易开始时间提前至北京时间16：00
|
| 2020-04-09 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the ten members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020;
3.To approve the compensation of our named executive officers on an advisory basis (“say-on-pay”);
4.To approve the Colfax Corporation 2020 Omnibus Incentive Plan;
5.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2019-04-02 |
股东大会：
将于2019-05-13召开股东大会
会议内容 ▼▲
- 1.To elect the nine members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2019;
3.To hold an advisory vote to approve the compensation of our named executive officers (“say-on-pay”);
4.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2018-04-05 |
股东大会：
将于2018-05-17召开股东大会
会议内容 ▼▲
- 1.To elect the nine members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2018;
3.To hold an advisory vote to approve the compensation of our named executive officers (“say-on-pay”);
4.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2017-04-04 |
股东大会：
将于2017-05-18召开股东大会
会议内容 ▼▲
- 1.To elect the nine members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2017;
3.To hold an advisory vote to approve the compensation of our named executive officers (“say-on-pay”);
4.To hold an advisory vote on the frequency of future advisory votes to approve the compensation of our named executive officers (“say-on-frequency”);
5.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|
| 2016-04-01 |
股东大会：
将于2016-05-13召开股东大会
会议内容 ▼▲
- 1.To elect the eight members of the Board of Directors named in the attached proxy statement;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2016;
3.To approve the adoption of the Colfax Corporation 2016 Omnibus Incentive Plan;
4.To consider any other matters that properly come before the Annual Meeting or any adjournment or postponement thereof.
|